论文部分内容阅读
日本国内和海外市场双双实现的销售增长推动日本曹达公司上一财年(截至2012年3月31日)农化销售额提高5.8%,达365.74亿日元(当前汇率计,约合4.59亿美元)。营业收入上升20.1%,达21.24亿日元(2700万美元)。国内市场受杀菌剂双胍辛胺乙酸盐(iminoctadine triacetate)、杀虫剂虫酰肼(tebufenozide)以及杀虫剂啶虫脒的新配方推出获得较高的销售所带动,日本国内销售额占销售总额的52%。公司在2010年收购陶氏益农虫酰肼业务。
Japan’s domestic and overseas markets both to achieve sales growth contributed to the Japanese company last fiscal year (up to March 31, 2012) agricultural sales increased 5.8% to 365.74 billion yen (the current exchange rate of about 459 million USD). Operating income rose 20.1% to 2.124 billion yen (27 million U.S. dollars). The domestic market was driven by higher sales of the new formulations of the biocide iminoctadine triacetate, the insecticide tebufenozide and the insecticide acetamiprid, with sales in Japan accounting for sales 52% of the total. The company acquired Dow benefits pest hydrazide business in 2010.